BE826086A - Preparation pharmaceutique orale a activite androgene - Google Patents

Preparation pharmaceutique orale a activite androgene

Info

Publication number
BE826086A
BE826086A BE153836A BE153836A BE826086A BE 826086 A BE826086 A BE 826086A BE 153836 A BE153836 A BE 153836A BE 153836 A BE153836 A BE 153836A BE 826086 A BE826086 A BE 826086A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparation
oral pharmaceutical
androgenic activity
androgenic
activity
Prior art date
Application number
BE153836A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826086A publication Critical patent/BE826086A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE153836A 1974-02-28 1975-02-27 Preparation pharmaceutique orale a activite androgene BE826086A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7402689,A NL189235C (nl) 1974-02-28 1974-02-28 Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Publications (1)

Publication Number Publication Date
BE826086A true BE826086A (fr) 1975-08-27

Family

ID=19820854

Family Applications (1)

Application Number Title Priority Date Filing Date
BE153836A BE826086A (fr) 1974-02-28 1975-02-27 Preparation pharmaceutique orale a activite androgene

Country Status (11)

Country Link
US (1) US4220599A (fi)
BE (1) BE826086A (fi)
CA (1) CA1038760A (fi)
DE (1) DE2508615A1 (fi)
FR (1) FR2262527B1 (fi)
GB (1) GB1500374A (fi)
HU (1) HU173417B (fi)
IE (1) IE40681B1 (fi)
NL (1) NL189235C (fi)
PH (1) PH13807A (fi)
ZA (1) ZA751007B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7506407A (nl) * 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
GB1567515A (en) * 1976-05-28 1980-05-14 Akzo Nv Esters of testo-sterone and 5 -dihydro-testosterone
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof
ATE311201T1 (de) * 2000-08-23 2005-12-15 Akzo Nobel Nv Testosteron-ester formulierung zur anwendung am menschen
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
US20050287203A1 (en) * 2002-05-08 2005-12-29 Nijs De H Formulation comprising testosteron undecanoate and castor oil
RU2429850C2 (ru) 2005-04-15 2011-09-27 Кларус Терапьютикс, Инк. Фармацевтические системы доставки для гидрофобных лекарственных средств и композиций, их содержащих
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) * 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) * 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
ES2749008T3 (es) 2014-06-17 2020-03-18 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855341A (en) * 1954-07-02 1958-10-07 Ciba Pharm Prod Inc Testosterone compositions
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3374230A (en) * 1966-04-26 1968-03-19 Schering Corp Acetylation of steroidal alcohols with ketene
CH502325A (de) * 1966-12-09 1971-01-31 Ciba Geigy Ag Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation

Also Published As

Publication number Publication date
FR2262527B1 (fi) 1978-08-04
CA1038760A (en) 1978-09-19
DE2508615C2 (fi) 1989-10-12
US4220599A (en) 1980-09-02
FR2262527A1 (fi) 1975-09-26
NL7402689A (nl) 1975-09-01
HU173417B (hu) 1979-05-28
NL189235C (nl) 1993-02-16
AU7838675A (en) 1976-08-26
IE40681B1 (en) 1979-08-01
NL189235B (nl) 1992-09-16
PH13807A (en) 1980-10-01
ZA751007B (en) 1976-01-28
DE2508615A1 (de) 1975-09-04
IE40681L (en) 1975-08-28
GB1500374A (en) 1978-02-08

Similar Documents

Publication Publication Date Title
BE826086A (fr) Preparation pharmaceutique orale a activite androgene
FR2304354A1 (fr) Nouvelles compositions pharmaceutiques a activite retardee
AT347588B (de) Arzneimittelwirkstofftraeger
IT1015421B (it) Sedia a rotelle
NL7514012A (nl) Farmaceutische capsules.
BE778285A (fr) Composes steroides a activite anti-phlogistique
BE871584A (fr) Preparations pharmaceutiques
FR2350102A1 (fr) Composition pharmaceutique analgesique
ZA75530B (en) New derivatives of tyrosine having a pharmaceutical activity on smooth muscles
DK360875A (da) Fremgangsmade til fremstilling at et legemiddel i pelletform
FR2287223A1 (fr) Composition pharmaceutique
NL7505240A (nl) Farmaceutisch preparaat.
BE824341A (fr) Compositions pharmaceutiques a activite analgesique
BE828690A (fr) Composes a activite anti-allergique
AT348137B (de) Desinfektionsmittel-zubereitung
IT8349395A0 (it) Prerarato farmaceutico a base di di gossina per ingestione orale
FR2290196A1 (fr) Composition pharmaceutique
BE820937A (fr) Composition pharmaceutique a activite antiallergique
BE820791A (fr) Composition pharmaceutique a activite anti-allergique
BE816376A (fr) Compositions pharmaceutiques a base de creatine-phosphate et decreatine-phosphokinase
BE838507A (fr) Comprimes pharmaceutiques
FR2321283A1 (fr) Medicament nouveau a activite antibacterienne
BE776788A (fr) Preparations pharmaceutiques a activite anesthesique
FR2285871A1 (fr) Compositions pharmaceutiques
FR2286646A1 (fr) Derives de l'acide 2-naphtyl-butyrique a activite therapeutique

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: AKZO N.V.

Effective date: 19950227